Free access to direct-acting antivirals in Spain: more favorable impact on hepatitis C mortality among highly educated people.
Julieta PolitiEnrique RegidorMarta DonatJosé PulidoJuan Miguel GuerrasGregorio BarrioMaría José BelzaPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
Results suggest that DAA treatments had a very favorable impact on hepatitis C mortality at all education levels. However, even in a universal and free health care system, highly educated people seem to benefit more from DAA treatment than less educated people.